Claus Kim Høgdall

Claus Kim Høgdall

Professor

Member of:

  • Obstetrics and Gynaecology


  1. 2010
  2. Published

    Serum tetranectin as a preoperative indicator for postoperative complications in Danish ovarian cancer patients

    Begum, F. D., Høgdall, Estrid Vilma Solyom, Christensen, I. J., Christensen, L. H., Kjær, S. K., Blaakaer, J., Petri, A. L., Høgdall, Claus Kim & Kjær, S., 2010, In: Gynecologic Oncology. 117, 3, p. 446-50 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study

    Doherty, J. A., Rossing, M. A., Cushing-Haugen, K. L., Chen, C., Van Den Berg, D. J., Wu, A. H., Pike, M. C., Ness, R. B., Moysich, K., Chenevix-Trench, G., Beesley, J., Webb, P. M., Chang-Claude, J., Wang-Gohrke, S., Goodman, M. T., Lurie, G., Thompson, P. J., Carney, M. E., Hogdall, E., Kjaer, S. K. & 31 others, Høgdall, Claus Kim, Goode, E. L., Cunningham, J. M., Fridley, B. L., Vierkant, R. A., Berchuck, A., Moorman, P. G., Schildkraut, J. M., Palmieri, R. T., Cramer, D. W., Terry, K. L., Yang, H. P., Garcia-Closas, M., Chanock, S., Lissowska, J., Song, H., Pharoah, P. D. P., Shah, M., Perkins, B., McGuire, V., Whittemore, A. S., Di Cioccio, R. A., Gentry-Maharaj, A., Menon, U., Gayther, S. A., Ramus, S. J., Ziogas, A., Brewster, W., Anton-Culver, H., Pearce, C. L. & Australian Ovarian Cancer Study Management Group, A. O. C. S. M. G., 1 Jan 2010, In: Cancer Epidemiology, Biomarkers & Prevention. 19, 1, p. 245-50 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Serum tetranectin is a significant prognostic marker in ovarian cancer patients

    Begum, F. D., Høgdall, Estrid Vilma Solyom, Christensen, I. J., Kjær, S. K., Blaakaer, J., Christensen, L. H., Høgdall, Claus Kim & Kjær, S., 1 Jan 2010, In: Acta Obstetricia et Gynecologica Scandinavica. 89, 2, p. 190-8 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium

    Phelan, C. M., Tsai, Y-Y., Goode, E. L., Vierkant, R. A., Fridley, B. L., Beesley, J., Chen, X. Q., Webb, P. M., Chanock, S., Cramer, D. W., Moysich, K., Edwards, R. P., Chang-Claude, J., Garcia-Closas, M., Yang, H., Wang-Gohrke, S., Hein, R., Green, A. C., Lissowska, J., Carney, M. E. & 31 others, Lurie, G., Wilkens, L. R., Ness, R. B., Pearce, C. L., Wu, A. H., Van Den Berg, D. J., Stram, D. O., Terry, K. L., Whiteman, D. C., Whittemore, A. S., DiCioccio, R. A., McGuire, V., Doherty, J. A., Rossing, M. A., Anton-Culver, H., Ziogas, A., Høgdall, Claus Kim, Hogdall, E., Krüger Kjaer, S., Blaakaer, J., Quaye, L., Ramus, S. J., Jacobs, I., Song, H., Pharoah, P. D. P., Iversen, E. S., Marks, J. R., Pike, M. C., Gayther, S. A., Cunningham, J. M. & Ovarian Cancer Association Consortium, Australian Cancer Study (Ovarian Cancer), O. C. A. C. A. C. S. (. C., 1 Feb 2010, In: Cancer Epidemiology, Biomarkers & Prevention. 19, 2, p. 600-4 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Comparison of proteomic biomarker panels in urine and serum for ovarian cancer diagnosis

    Petri, A. L., Simonsen, A. H., Høgdall, Estrid Vilma Solyom, Christensen, I. J., Kjaer, S. K., Yip, C., Risum, S. N., Pedersen, Anette Tønnes, Hartwell, D., Fung, E. T. & Høgdall, Claus Kim, 1 Mar 2010, In: Proteomics - Clinical Applications. 4, 3, p. 304-14 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer?

    Risum, S., Høgdall, Claus Kim, Loft, A., Berthelsen, A. K., Høgdall, Estrid Vilma Solyom, Nedergaard, L., Lundvall, L., Engelholm, S. A. & Loft, A., 1 Mar 2010, In: Gynecologic Oncology. 116, 3, p. 395-8 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot"

    Johnatty, S. E., Beesley, J., Chen, X., Macgregor, S., Duffy, D. L., Spurdle, A. B., deFazio, A., Gava, N., Webb, P. M., Rossing, M. A., Doherty, J. A., Goodman, M. T., Lurie, G., Thompson, P. J., Wilkens, L. R., Ness, R. B., Moysich, K. B., Chang-Claude, J., Wang-Gohrke, S., Cramer, D. W. & 31 others, Terry, K. L., Hankinson, S. E., Tworoger, S. S., Garcia-Closas, M., Yang, H., Lissowska, J., Chanock, S. J., Pharoah, P. D., Song, H., Whitemore, A. S., Pearce, C. L., Stram, D. O., Wu, A. H., Pike, M. C., Gayther, S. A., Ramus, S. J., Menon, U., Gentry-Maharaj, A., Anton-Culver, H., Ziogas, A., Hogdall, E., Kjaer, S. K., Høgdall, Claus Kim, Berchuck, A., Schildkraut, J. M., Iversen, E. S., Moorman, P. G., Phelan, C. M., Sellers, T. A., Cunningham, J. M. & Ovarian Cancer Association Consortium, O. C. A. C., 1 Jul 2010, In: P L o S Genetics. 6, 7, p. e1001016

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Limited prognostic value of tissue protein expression levels of BCl-2 in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study

    Høgdall, Estrid Vilma Solyom, Christensen, L. H., Kjaer, S. K., Blaakaer, J., Christensen, I. J. & Høgdall, Claus Kim, 1 Aug 2010, In: Acta Pathologica Microbiologica et Immunologica Scandinavica. 118, 8, p. 557-64 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Perioperativ behandling af ovariecancer i stadium IIIC

    Hjort Jakobsen, D., Høgdall, Claus Kim & Kehlet, Henrik, 27 Sep 2010, In: Ugeskrift for Laeger. 172, 39, p. 2688-91 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24

    Goode, E. L., Chenevix-Trench, G., Song, H., Ramus, S. J., Notaridou, M., Lawrenson, K., Widschwendter, M., Vierkant, R. A., Larson, M. C., Kjaer, S. K., Birrer, M. J., Berchuck, A., Schildkraut, J., Tomlinson, I., Kiemeney, L. A., Cook, L. S., Gronwald, J., Garcia-Closas, M., Gore, M. E., Campbell, I. & 31 others, Whittemore, A. S., Sutphen, R., Phelan, C., Anton-Culver, H., Pearce, C. L., Lambrechts, D., Rossing, M. A., Chang-Claude, J., Moysich, K. B., Goodman, M. T., Dörk, T., Nevanlinna, H., Ness, R. B., Rafnar, T., Høgdall, Claus Kim, Hogdall, E., Fridley, B. L., Cunningham, J. M., Sieh, W., McGuire, V., Godwin, A. K., Cramer, D. W., Hernandez, D., Levine, D., Lu, K., Iversen, E. S., Palmieri, R. T., Houlston, R., van Altena, A. M., Aben, K. K. H. & Wellcome Trust Case-Control Consortium, W. T. C. C., 1 Oct 2010, In: Nature Genetics. 42, 10, p. 874-9 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...24 Next

ID: 983775